Sangamo Therapeutics
SGMO
SGMO
195 hedge funds and large institutions have $458M invested in Sangamo Therapeutics in 2022 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 57 increasing their positions, 56 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
2% more repeat investments, than reductions
Existing positions increased: 57 | Existing positions reduced: 56
20% less capital invested
Capital invested by funds: $571M → $458M (-$114M)
Holders
195
Holding in Top 10
–
Calls
$3.64M
Puts
$1.95M
Top Buyers
| 1 | +$9.34M | |
| 2 | +$5.12M | |
| 3 | +$4.73M | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$3.65M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$3.57M |
Top Sellers
| 1 | -$4.04M | |
| 2 | -$3.65M | |
| 3 | -$2.56M | |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$2.39M |
| 5 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$2.28M |